Literature DB >> 27804254

Are all metabolically healthy individuals with obesity at the same risk of diabetes onset?

David Navarro-González1, Laura Sánchez-Íñigo1, Alejandro Fernández-Montero2,3, Juan Pastrana-Delgado3,4, J Alfredo Martínez3,5,6.   

Abstract

OBJECTIVE: To examine the risk of diabetes and the development of an unhealthy status according to metabolic health. To assess the effect of changes in metabolic health among participants with metabolically healthy obesity (MHO) on the risk of diabetes.
METHODS: A total of 4,340 subjects were included. Unhealthy metabolic status was defined as having three or more risk factors of the Adult Treatment Panel-III criteria. A Cox proportional-hazard analysis was conducted to estimate the hazard ratio (HR) of developing diabetes across the change in the metabolic status of subjects with MHO.
RESULTS: After 40,622 person-years of follow-up, the risk of becoming unhealthy was 1.53 times higher for participants with MHO, compared with lean or overweight healthy subjects. A greater risk of diabetes was found in MHO, but it was attributable to those who progressed to an unhealthier status over time: HR of 4.78 (95% CI: 3.38-6.78). The combination of being metabolically unhealthy and obesity heightened the risk of diabetes: HR of 10.09 (95% CI: 4.82-21.55).
CONCLUSIONS: The increased risk of diabetes in MHO is attributed to the progression to an unhealthier state. "Healthy obesity" is not a permanent situation but a transitory state.
© 2016 The Obesity Society.

Entities:  

Mesh:

Year:  2016        PMID: 27804254     DOI: 10.1002/oby.21667

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

1.  Relationship Between Adiponectin and apoB in Individuals With Diabetes in the Atlantic PATH Cohort.

Authors:  Vanessa DeClercq; Yunsong Cui; Trevor J B Dummer; Cynthia Forbes; Scott A Grandy; Melanie Keats; Louise Parker; Ellen Sweeney; Zhijie Michael Yu; Roger S McLeod
Journal:  J Endocr Soc       Date:  2017-11-08

Review 2.  Off-label drugs for weight management.

Authors:  Ed J Hendricks
Journal:  Diabetes Metab Syndr Obes       Date:  2017-06-10       Impact factor: 3.168

3.  Risk of type 2 diabetes according to the cumulative exposure to metabolic syndrome or obesity: A nationwide population-based study.

Authors:  You-Bin Lee; Da Hye Kim; Seon Mee Kim; Nan Hee Kim; Kyung Mook Choi; Sei Hyun Baik; Yong Gyu Park; Kyungdo Han; Hye Jin Yoo
Journal:  J Diabetes Investig       Date:  2020-06-28       Impact factor: 4.232

Review 4.  Metabolically healthy obesity: Is it really healthy for type 2 diabetes mellitus?

Authors:  Qi Wu; Ming-Feng Xia; Xin Gao
Journal:  World J Diabetes       Date:  2022-02-15

5.  Short-Term Changes in Metabolically Healthy Overweight/Obesity Status Impact the Susceptibility to Type 2 Diabetes in Chinese Adults.

Authors:  Jie Min; Xiang Hu; Jiaoyue Zhang; Tianshu Zeng; Ying Wang; Shenghua Tian; Geng Liu; Xueyu Zhong; Kangli Qiu; Miaomiao Peng; Lulu Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

6.  Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study.

Authors:  P T Bradshaw; K R Reynolds; L E Wagenknecht; C E Ndumele; J Stevens
Journal:  Int J Obes (Lond)       Date:  2017-10-09       Impact factor: 5.095

7.  Impact of the Dynamic Change of Metabolic Health Status on the Incident Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

Authors:  Jung A Kim; Da Hye Kim; Seon Mee Kim; Yong Gyu Park; Nan Hee Kim; Sei Hyun Baik; Kyung Mook Choi; Kyungdo Han; Hye Jin Yoo
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12

8.  Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank.

Authors:  Zimin Song; Meng Gao; Jun Lv; Canqing Yu; Yu Guo; Zheng Bian; Yuxia Wei; Ling Yang; Huaidong Du; Yiping Chen; Jianqiang Zhang; Jvying Yao; Junshi Chen; Zhengming Chen; Tao Huang; Liming Li
Journal:  Eur J Endocrinol       Date:  2022-01-06       Impact factor: 6.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.